Innovative Blood Monitoring PyrAmes specializes in non-invasive, continuous blood pressure monitoring technology for critically-ill infants and potentially other vulnerable patient groups, providing a unique selling proposition for hospitals and clinics seeking advanced patient monitoring solutions.

Regulatory Milestones With FDA Breakthrough Device Designation and recent 510(k) market clearance for Boppli, PyrAmes demonstrates robust regulatory progress, making their solutions more attractive to healthcare providers prioritizing proven and approved medical devices.

Strong Industry Recognition Awards like the AAP SOATT pediatric device award and recognition from Ignite Healthcare Networks position PyrAmes as an innovative player in pediatric and healthcare technology markets, opening doors for partnerships and endorsements.

Growth and Funding Having secured $6 million in Series A funding and achieved impressive revenue estimates, PyrAmes is positioned for market expansion, offering sales opportunities to healthcare organizations looking to adopt cutting-edge medical devices.

Strategic Collaborations Partnerships such as with Plug & Play Ventures and other international accelerators facilitate business development efforts by providing access to new markets and potential joint ventures for sales channels globally.